{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:28:26Z","timestamp":1775665706311,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003000","name":"Stichting MS Research","doi-asserted-by":"publisher","award":["14-358e"],"award-info":[{"award-number":["14-358e"]}],"id":[{"id":"10.13039\/501100003000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00415-015-8001-3","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T03:35:45Z","timestamp":1453692945000},"page":"649-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Concomitant granule cell neuronopathy in patients with natalizumab-associated PML"],"prefix":"10.1007","volume":"263","author":[{"given":"Martijn T.","family":"Wijburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorine","family":"Siepman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen J. J.","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joep","family":"Killestein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike P.","family":"Wattjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"8001_CR1","first-page":"667","volume":"6","author":"BJ Brew","year":"2010","unstructured":"Brew BJ, Davies NWS, Cinque P et al (2010) Progressive multifocal leukoencephalopathy and other forms of JC virus disease. NatRevNeurol 6:667\u2013679","journal-title":"NatRevNeurol"},{"key":"8001_CR2","first-page":"680","volume":"12","author":"I Steiner","year":"2012","unstructured":"Steiner I, Berger JR (2012) Update on progressive multifocal leukoencephalopathy. CurrNeurolNeurosciRep 12:680\u2013686","journal-title":"Update on progressive multifocal leukoencephalopathy. CurrNeurolNeurosciRep"},{"key":"8001_CR3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamaneurol.2013.598","volume":"70","author":"R Rudick","year":"2013","unstructured":"Rudick R, Polman C, Clifford D et al (2013) Natalizumab: bench to bedside and beyond. JAMA Neurol 70:172\u2013182","journal-title":"JAMA Neurol"},{"key":"8001_CR4","unstructured":"Biogen MedInfo. http:\/\/medinfo.biogen.com . Accessed 3rd June 2015"},{"key":"8001_CR5","first-page":"1826","volume":"19","author":"MP Wattjes","year":"2013","unstructured":"Wattjes MP, Richert ND, Killestein J et al (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. MultScler 19:1826\u20131840","journal-title":"MultScler"},{"key":"8001_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","volume":"9","author":"CS Tan","year":"2010","unstructured":"Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9:425\u2013437","journal-title":"Lancet Neurol"},{"key":"8001_CR7","first-page":"576","volume":"57","author":"IJ Koralnik","year":"2005","unstructured":"Koralnik IJ, Wuthrich C, Dang X et al (2005) JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. AnnNeurol 57:576\u2013580. doi: 10.1002\/ana.20431","journal-title":"AnnNeurol"},{"key":"8001_CR8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/01.WNL.0000081306.86961.33","volume":"61","author":"RA Pasquier Du","year":"2003","unstructured":"Du Pasquier RA, Corey S, Margolin DH et al (2003) Productive infection of cerebellar granule cell neurons by JC virus in an HIV+\u00a0individual. Neurology 61:775\u2013782","journal-title":"Neurology"},{"key":"8001_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00415-014-7530-5","volume":"262","author":"MT Wijburg","year":"2015","unstructured":"Wijburg MT, van Oosten BW, Murk JL et al (2015) Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature. J Neurol 262:65\u201373. doi: 10.1007\/s00415-014-7530-5","journal-title":"J Neurol"},{"key":"8001_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamaneurol.2013.4668","volume":"71","author":"L Dang","year":"2014","unstructured":"Dang L, Dang X, Koralnik IJ, Todd PK (2014) JC Polyomavirus Granule Cell Neuronopathy in a Patient Treated With Rituximab. JAMA Neurol 71:487\u2013489. doi: 10.1001\/jamaneurol.2013.4668","journal-title":"JAMA Neurol"},{"key":"8001_CR11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2015.05.003","volume":"354","author":"C Henry","year":"2015","unstructured":"Henry C, Jouan F, De Broucker T (2015) JC virus granule cell neuronopathy: a cause of infectious cerebellar degeneration. J Neurol Sci 354:86\u201390. doi: 10.1016\/j.jns.2015.05.003","journal-title":"J Neurol Sci"},{"key":"8001_CR12","first-page":"622","volume":"74","author":"S Schippling","year":"2013","unstructured":"Schippling S, Kempf C, Buchele F et al (2013) JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment. AnnNeurol 74:622\u2013626. doi: 10.1002\/ana.23973","journal-title":"AnnNeurol"},{"key":"8001_CR13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1212\/WNL.0000000000000713","volume":"83","author":"SP Agnihotri","year":"2014","unstructured":"Agnihotri SP, Dang X, Carter JL et al (2014) JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology 83:727\u2013732. doi: 10.1212\/WNL.0000000000000713","journal-title":"Neurology"},{"key":"8001_CR14","first-page":"222","volume":"47","author":"F Bustamante","year":"2009","unstructured":"Bustamante F, Luis Cartier R, Manuel Lavados M (2009) Atrofia cerebelosa por el virus JC en un paciente con SIDA. Rev Chin Neurro-Psiquiat 47:222\u2013227","journal-title":"Rev Chin Neurro-Psiquiat"},{"key":"8001_CR15","first-page":"15","volume":"68","author":"C Wuthrich","year":"2009","unstructured":"Wuthrich C, Cheng YM, Joseph JT et al (2009) Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. JNeuropatholExpNeurol 68:15\u201325","journal-title":"JNeuropatholExpNeurol"},{"key":"8001_CR16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jnnp-2014-308630","volume":"86","author":"MP Wattjes","year":"2015","unstructured":"Wattjes MP, Vennegoor A, Steenwijk MD et al (2015) MRI pattern in asymptomatic natalizumab-associated PML. J Neurol Neurosurg Psychiatry 86:793\u2013798. doi: 10.1136\/jnnp-2014-308630","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8001_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/brain\/122.2.291","volume":"122","author":"SG Edwards","year":"1999","unstructured":"Edwards SG, Gong QY, Liu C et al (1999) Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 122:291\u2013301","journal-title":"Brain"},{"key":"8001_CR18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","volume":"11","author":"MP Wattjes","year":"2015","unstructured":"Wattjes MP, Rovira \u00c0, Miller D et al (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis\u2014establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597\u2013606","journal-title":"Nat Rev Neurol"},{"key":"8001_CR19","doi-asserted-by":"crossref","unstructured":"Wattjes MP, Wijburg MT, Vennegoor A, et al. (2015) MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. J Neurol Neurosurg Psychiatry doi: 10.1136\/jnnp-2015-311411","DOI":"10.1136\/jnnp-2015-311411"},{"key":"8001_CR20","author":"MP Wattjes","year":"2015","unstructured":"Wattjes MP, Wijburg MT, Vennegoor A et al (2015) Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients. Mult Scler. doi: 10.1177\/1352458515615225","journal-title":"Mult Scler"},{"key":"8001_CR21","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80:1430\u20131438","journal-title":"Neurology"},{"key":"8001_CR22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000117270","volume":"36","author":"F Pasquier","year":"1996","unstructured":"Pasquier F, Leys D, Weerts JG et al (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268\u2013272","journal-title":"Eur Neurol"},{"key":"8001_CR23","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","volume":"21","author":"ELGE Koedam","year":"2011","unstructured":"Koedam ELGE, Lehmann M, van der Flier WM et al (2011) Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 21:2618\u20132625. doi: 10.1007\/s00330-011-2205-4","journal-title":"Eur Radiol"},{"key":"8001_CR24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jocn.2008.07.091","volume":"16","author":"R Granot","year":"2009","unstructured":"Granot R, Lawrence R, Barnett M et al (2009) What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis. J Clin Neurosci 16:1091\u20131092. doi: 10.1016\/j.jocn.2008.07.091","journal-title":"J Clin Neurosci"},{"key":"8001_CR25","first-page":"2533","volume":"87","author":"X Dang","year":"2006","unstructured":"Dang X, Koralnik IJ (2006) A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. JGenVirol 87:2533\u20132537","journal-title":"JGenVirol"},{"key":"8001_CR26","first-page":"175","volume":"93","author":"X Dang","year":"2012","unstructured":"Dang X, Vidal JE, De Oliveira ACP et al (2012) JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. JGenVirol 93:175\u2013183. doi: 10.1099\/vir.0.037440-0","journal-title":"JGenVirol"},{"key":"8001_CR27","first-page":"1139","volume":"261","author":"MP Wattjes","year":"2014","unstructured":"Wattjes MP, Vennegoor A, Mostert J et al (2014) Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place? JNeurol 261:1139\u20131143. doi: 10.1007\/s00415-014-7336-5","journal-title":"JNeurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-8001-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-8001-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-8001-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:07:56Z","timestamp":1553612876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-8001-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["8001"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-8001-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]}}}